IP-10 induces dissociation of newly formed blood vessels

  • Richard J. Bodnar
    Pittsburgh Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA
  • Cecelia C. Yates
    Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA
  • Margaret E. Rodgers
    Pittsburgh Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA
  • Xiaoping Du
    Department of Pharmacology, University of Illinois, Chicago, IL 60612, USA
  • Alan Wells
    Pittsburgh Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA

説明

<jats:p>The signals that prune the exuberant vascular growth of tissue repair are still ill defined. We demonstrate that activation of CXC chemokine receptor 3 (CXCR3) mediates the regression of newly formed blood vessels. We present evidence that CXCR3 is expressed on newly formed vessels in vivo and in vitro. CXCR3 is expressed on vessels at days 7-21 post-wounding, and is undetectable in unwounded or healed skin. Treatment of endothelial cords with CXCL10 (IP-10), a CXCR3 ligand present during the resolving phase of wounds, either in vitro or in vivo caused dissociation even in the presence of angiogenic factors. Consistent with this, mice lacking CXCR3 express a greater number of vessels in wound tissue compared to wild-type mice. We then hypothesized that signaling from CXCR3 not only limits angiogenesis, but also compromises vessel integrity to induce regression. We found that activation of CXCR3 triggers μ-calpain activity, causing cleavage of the cytoplasmic tail of β3 integrins at the calpain cleavage sites c'754 and c'747. IP-10 stimulation also activated caspase 3, blockage of which prevented cell death but not cord dissociation. This is the first direct evidence for an extracellular signaling mechanism through CXCR3 that causes the dissociation of newly formed blood vessels followed by cell death.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ